Sangamo BioSciences | SGMO - Trade Creditors


Sangamo BioSciences reported $10.74M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 843K 34K Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Amgen USD 20.89B 1.25B Dec/2025
Bayer EUR 6.38B 343M Sep/2025
BioCryst Pharmaceuticals USD 5.57M 3.02M Sep/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 9.12M 7.33M Sep/2025
CSL USD 3.46B 484M Jun/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 1.04B 183.31M Jun/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sanofi EUR 22.93B 927M Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Tectonic Therapeutic USD 1.48M 1.32M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025